- Home
- SBLK vs WGS Comparison
SBLK vs WGS Comparison
Compare SBLK & WGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SBLK
- WGS
- Stock Information
- Founded
- SBLK 2006
- WGS 2017
- Country
- SBLK Greece
- WGS United States
- Employees
- SBLK N/A
- WGS N/A
- Industry
- SBLK Marine Transportation
- WGS Retail: Computer Software & Peripheral Equipment
- Sector
- SBLK Consumer Discretionary
- WGS Technology
- Exchange
- SBLK Nasdaq
- WGS Nasdaq
- Market Cap
- SBLK 1.8B
- WGS 2.0B
- IPO Year
- SBLK N/A
- WGS N/A
- Fundamental
- Price
- SBLK $15.35
- WGS $95.83
- Analyst Decision
- SBLK Strong Buy
- WGS Strong Buy
- Analyst Count
- SBLK 3
- WGS 5
- Target Price
- SBLK $22.67
- WGS $82.60
- AVG Volume (30 Days)
- SBLK 2.2M
- WGS 1.5M
- Earning Date
- SBLK 02-18-2025
- WGS 02-18-2025
- Dividend Yield
- SBLK 13.94%
- WGS N/A
- EPS Growth
- SBLK 60.00
- WGS N/A
- EPS
- SBLK 2.80
- WGS N/A
- Revenue
- SBLK $1,265,458,000.00
- WGS $305,450,000.00
- Revenue This Year
- SBLK N/A
- WGS $44.70
- Revenue Next Year
- SBLK $17.26
- WGS $16.73
- P/E Ratio
- SBLK $5.48
- WGS N/A
- Revenue Growth
- SBLK 33.31
- WGS 50.79
- 52 Week Low
- SBLK $14.30
- WGS $7.16
- 52 Week High
- SBLK $27.47
- WGS $115.60
- Technical
- Relative Strength Index (RSI)
- SBLK 48.10
- WGS 59.30
- Support Level
- SBLK $14.74
- WGS $65.10
- Resistance Level
- SBLK $17.00
- WGS $115.60
- Average True Range (ATR)
- SBLK 0.52
- WGS 9.03
- MACD
- SBLK 0.02
- WGS 3.96
- Stochastic Oscillator
- SBLK 26.99
- WGS 65.30
About SBLK Star Bulk Carriers Corp.
Star Bulk Carriers Corp provides seaborne transportation solutions in the dry bulk sector. The company owns and operates dry bulk carrier vessels, which are used to transport bulk, such as iron ore, coal, grains, bauxite, fertilizers, and steel products. It owns a fleet of vessels that consists of Newcastlemax, Capesize, Post Panamax, Kamsarmax, Panamax, Ultramax, and Supramax. It generates revenues through the voyages it carries out.
About WGS GeneDx Holdings Corp.
GeneDx Holdings Corp delivers personalized and actionable health insights to inform diagnosis, direct treatment and improve drug discovery. The company is uniquely positioned to accelerate the use of genomic and large-scale clinical information to enable precision medicine as the standard of care. GeneDx is at the forefront of transforming healthcare through its various exome and genome testing and interpretation, fueled by one of the world's substantial rare disease data sets.